FDA Asks Narcolepsy Patients How Symptoms Change Over Time
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency plans a half-day meeting Sept. 24 on narcolepsy symptom burden and current treatment options, part of its patient-focused drug development initiative under PDUFA V.